Rani Therapeutics Holdings (RANI) has grabbed attention after announcing a collaboration and license agreement with Chugai Pharmaceutical for an oral rare disease therapy. The deal includes payments ...
In 'Tomader Rani', Rani faces a crisis as her daughter is abducted during her exam. With the support of her husband Durjoy, they desperately search for Duni. The show created by Susanta Das depicts ...
The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...
) has been revised to $9.44 / share. This is a decrease of 11.90% from the prior estimate of $10.71 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® ...
Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the press ...
Dewas (Madhya Pradesh): The auspicious nine days of Shardiya Navratri have drawn to a close, marked by the joyous celebration of this festival. Devotees in every household participated in worship, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback